PapersFlow Research Brief
Nosocomial Infections in ICU
Research Guide
What is Nosocomial Infections in ICU?
Nosocomial infections in ICU are healthcare-associated infections acquired by intensive care unit patients, primarily focusing on ventilator-associated pneumonia (VAP), bloodstream infections, and sepsis, with emphasis on their epidemiology, prevention through guidelines, antibiotic therapy, and impact on patient outcomes.
The field encompasses 37,940 papers on management, diagnosis, treatment, and prevention of VAP and related nosocomial infections in ICU settings. Key areas include antibiotic therapy, respiratory tract decontamination, microbial investigation, and evidence-based prevention guidelines. Growth rate over the past 5 years is not available.
Topic Hierarchy
Research Sub-Topics
Ventilator-Associated Pneumonia Epidemiology
This sub-topic examines the incidence, prevalence, risk factors, and pathogen distribution of VAP in ICU settings across different populations and regions. Researchers analyze surveillance data and conduct cohort studies to identify trends and predictors of VAP development.
Ventilator Bundle Prevention Strategies
This sub-topic focuses on evidence-based bundles including head-of-bed elevation, daily sedation interruption, and oral care to reduce VAP incidence. Researchers evaluate bundle implementation, compliance rates, and their impact on clinical outcomes through randomized trials and meta-analyses.
Antibiotic Therapy for VAP
This sub-topic investigates optimal empirical and targeted antibiotic regimens, de-escalation strategies, and duration of therapy for VAP caused by multidrug-resistant pathogens. Researchers study pharmacokinetic/pharmacodynamic optimization and stewardship programs in ICU settings.
Diagnostic Strategies for VAP
This sub-topic covers clinical, radiological, and microbiological diagnostic criteria including bronchoalveolar lavage and biomarkers like PCT and sTREM-1. Researchers validate new diagnostic tools to differentiate VAP from other conditions and improve early detection.
VAP Impact on Patient Outcomes
This sub-topic analyzes mortality, length of stay, ventilator days, and long-term morbidity attributable to VAP in ICU patients. Researchers use propensity matching and multivariate analyses to quantify VAP's independent effects on prognosis.
Why It Matters
Nosocomial infections in ICU contribute to high morbidity and mortality, with severe sepsis causing as many annual deaths as acute myocardial infarction, especially among the elderly, as shown by Angus et al. (2001) in 'Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care,' which analyzed incidence, outcomes, and costs. A multistate survey by Magill et al. (2014) in 'Multistate Point-Prevalence Survey of Health Care–Associated Infections' estimated health care-associated infection prevalence across 10 U.S. states, informing national burden estimates. Guidelines like 'Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016' by Rhodes et al. (2017) provide evidence-based management protocols, while 'Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia' (2005) address VAP-specific therapy, reducing ICU lengths of stay and costs in clinical practice.
Reading Guide
Where to Start
'Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care' by Angus et al. (2001), as it provides foundational U.S. data on sepsis incidence, mortality, and costs relevant to ICU nosocomial infections, with 8495 citations.
Key Papers Explained
Angus et al. (2001) 'Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care' establishes sepsis epidemiology baselines, which Martin et al. (2003) 'The Epidemiology of Sepsis in the United States from 1979 through 2000' extends with long-term trends and microbial shifts. Levy et al. (2003) '2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference' refines definitions for these infections, informing Rhodes et al. (2017) 'Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016' management protocols. Wisplinghoff et al. (2004) 'Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study' adds bloodstream infection specifics, while Horan et al. (2008) 'CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting' standardizes surveillance.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Evans et al. (2021) 'Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021' updates 2016 protocols with recent evidence on septic shock in ICU nosocomial contexts. Rudd et al. (2020) 'Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study' offers worldwide incidence data extending U.S.-focused epidemiology papers. Magill et al. (2014) 'Multistate Point-Prevalence Survey of Health Care–Associated Infections' provides prevalence metrics for ongoing surveillance needs.
Papers at a Glance
Frequently Asked Questions
What are the main types of nosocomial infections in ICU patients?
Primary types include ventilator-associated pneumonia (VAP), nosocomial bloodstream infections, and sepsis. 'CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting' by Horan et al. (2008) provides standardized criteria for these infections in acute care. VAP arises from endotracheal tubes and mechanical ventilation in ICU settings.
How prevalent are nosocomial bloodstream infections in US hospitals?
Wisplinghoff et al. (2004) analyzed 24,179 cases in 'Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study,' finding increasing proportions due to antibiotic-resistant organisms. These infections occur across ICU and non-ICU patients. Gram-positive bacteria and fungi contribute significantly.
What do guidelines recommend for managing VAP in ICU?
'Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia' (2005) outlines antibiotic therapy and prevention strategies for hospital-acquired and VAP. Recommendations include early appropriate antibiotics and de-escalation based on cultures. Prevention involves respiratory tract decontamination and VAP bundles.
What is the incidence trend of sepsis in the United States?
Martin et al. (2003) in 'The Epidemiology of Sepsis in the United States from 1979 through 2000' reported increasing sepsis incidence and deaths, though mortality rates declined. Disparities exist by race and sex, with rising Gram-positive and fungal cases. Angus et al. (2001) confirmed high costs and elderly prevalence.
How are sepsis definitions applied in ICU nosocomial infections?
Levy et al. (2003) in '2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference' expanded sepsis signs and symptoms without changing core definitions. These apply to ICU patients with nosocomial infections like VAP. Later updates appear in Rhodes et al. (2017) Surviving Sepsis guidelines.
Open Research Questions
- ? How can antibiotic resistance trends in nosocomial ICU bloodstream infections be reversed, given rising proportions reported in large surveillance studies?
- ? What specific prevention bundles most effectively reduce VAP incidence in diverse ICU populations?
- ? How do aging demographics impact future nosocomial sepsis burdens in ICUs?
- ? Which microbial shifts in VAP pathogens require updated decontamination protocols?
- ? What outcome disparities in nosocomial infections persist across races and sexes in ICU settings?
Recent Trends
No recent preprints or news coverage available in the past 6-12 months.
High citation counts persist for foundational works, with Evans et al. 'Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021' at 4449 citations indicating continued guideline evolution.
2021The field holds 37,940 papers, focusing on VAP prevention amid stable growth data.
Research Nosocomial Infections in ICU with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Nosocomial Infections in ICU with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers